Turing Pharmaceuticals CEO Announces to #HIVscoop Exclusively Timeframe for Drug Price Drop
When will the price drop of the drug Daraprim happen? That has been the question of national news outlets to Turing Pharmaceutical CEO Martin Shkreli since the internet firestorm surrounding a drug that his company effectively raised the price of to over $750/pill — $75,000 per bottle.
— Josh Robbins (@imstilljosh) October 31, 2015
Josh Robbins is an HIV positive activist, patient advocate and requested an interview with Shkreli via social media. “I simply sent him a DM on Twitter and asked him if I could interview him. He said, ‘sure’ and we set it up.” Robbins also hosts several podcasts and uses social media to increase awareness surrounding HIV. In one special newly launched social media series, #HIVscoop, he gets the pharma CEO to answer a handful of questions that mainstream media has so far failed to get Shkreli on record.
The entire hour-long video interview releases exclusively on imstilljosh.com on Monday.
Other questions include:
- Should you be fired?
- What will the price drop be?
- And new details on a new program for hospitals to acquire the drug more affordably.
- Plus Martin Shkreli announces that his family’s nonprofit, the Shkreli Foundation will be focusing on HIV/AIDS initiatives after offering to sponsor an event for HIV service organization, Whitman-Walker Health (D.C.). (The same organization Bernie Sanders forwarded a $2700 donation to after refusing to accept Shkreli’s $2700 political campaign contribution.)